420 related articles for article (PubMed ID: 36147518)
1. Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal.
Eljack S; David S; Faggad A; Chourpa I; Allard-Vannier E
Int J Pharm X; 2022 Dec; 4():100126. PubMed ID: 36147518
[TBL] [Abstract][Full Text] [Related]
2. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
[TBL] [Abstract][Full Text] [Related]
3. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
Li J; Wang Y; Zhu Y; Oupický D
J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
[TBL] [Abstract][Full Text] [Related]
5. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
6. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
7. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.
Zoulikha M; Xiao Q; Boafo GF; Sallam MA; Chen Z; He W
Acta Pharm Sin B; 2022 Feb; 12(2):600-620. PubMed ID: 34401226
[TBL] [Abstract][Full Text] [Related]
9. Chalepin: A Compound from
Richardson JSM; Aminudin N; Abd Malek SN
Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S489-S498. PubMed ID: 29142404
[TBL] [Abstract][Full Text] [Related]
10. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
13. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S
Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice.
Stamatopoulos A; Stamatopoulos T; Gamie Z; Kenanidis E; Ribeiro RDC; Rankin KS; Gerrand C; Dalgarno K; Tsiridis E
J Bone Oncol; 2019 Jun; 16():100231. PubMed ID: 30956944
[TBL] [Abstract][Full Text] [Related]
15. Good or not good: Role of miR-18a in cancer biology.
Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of p53 regulation of oxidative stress in skeletal muscle.
Beyfuss K; Hood DA
Redox Rep; 2018 Dec; 23(1):100-117. PubMed ID: 29298131
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanoparticles for drug and gene delivery.
Zhou Y; Quan G; Wu Q; Zhang X; Niu B; Wu B; Huang Y; Pan X; Wu C
Acta Pharm Sin B; 2018 Mar; 8(2):165-177. PubMed ID: 29719777
[TBL] [Abstract][Full Text] [Related]
18. Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage.
Ashraf U; Ding Z; Deng S; Ye J; Cao S; Chen Z
Virulence; 2021 Dec; 12(1):968-980. PubMed ID: 33724154
[TBL] [Abstract][Full Text] [Related]
19. Advances in delivery methods of
ElFar OA; Billa N; Lim HR; Chew KW; Cheah WY; Munawaroh HSH; Balakrishnan D; Show PL
Bioengineered; 2022 Jun; 13(6):14681-14718. PubMed ID: 35946342
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in drug delivery systems for targeting cancer stem cells.
Duan H; Liu Y; Gao Z; Huang W
Acta Pharm Sin B; 2021 Jan; 11(1):55-70. PubMed ID: 33532180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
